April 2020

Letter from the Editor

April 1, 2020

Inspiring Leadership Amid the COVID-19 global pandemic and the yet-to-be-determined devastation, it is heartening to see the heroic efforts being put forth by healthcare workers who are risking their own lives on the front lines of patient care. We are also seeing healthcare companies pivot their R&D programs to evaluate potential pipeline assets to combat […]

Upfront

April 1, 2020

BMS Undergoes Brand Transformation Bristol Myers Squibb has revealed a new brand to reflect its evolution in light of its acquisition of Celgene for $74 billion late last year. The changes reflect an updated website, logo, and a change in punctuation — removing the hyphen between Bristol and Myers. The company, which was founded in […]

HealthTech

April 1, 2020

Boehringer-Ingelheim Launches Patient-Centric MyStudyWindow Powered by Carebox Trend Watch: HealthTech Innovations Continue to Transform Patient Care Boehringer Ingelheim and Carebox Healthcare Solutions have launched MyStudyWindow, a digital platform empowering patients, families, caregivers, and doctors to learn about Boehringer Ingelheim’s studies by offering information in an easy to access and understandable way. The collaboration brings together […]

Artificial Intelligence

April 1, 2020

Microsoft Launches $40M Healthcare Artificial Intelligence Program Trend Watch: AI continues to gain traction worldwide in healthcare and pharma applications Microsoft has launched a 5-year, $40 million program called AI for Health, an initiative that will use artificial intelligence tools to address some of healthcare’s biggest challenges, including disease diagnosis and treatment and global health […]

Innovator’s Corner

April 1, 2020

COVID-19 The latest drug and vaccine innovations to counter this deadly virus. The rapidly moving target of the coronavirus is challenging the best of the world’s life-sciences innovators, and the landscape changes not only by the day but by the hour. At press time for this issue, these are the most current efforts being made […]

Last Word

April 1, 2020

Transforming the Practice of Medicine John Cox, CEO of Repertoire Immune Medicines — a clinical-stage immuno-therapy company — talks about unleashing the curative powers of the immune system to prevent and cure cancer, autoimmune, and infectious diseases. PV: Repertoire Therapeutics was launched late last year, tell us about its genesis. Cox: Our journey began when […]

Women of Influence

April 1, 2020

Leaders become great, not because of their power, but because of their ability to empower others – John Maxwell More than two dozen women who sit in seats of influence are using their talents, strategic acumen, and tenacity to create change throughout the life-sciences industry and their organizations. They are stalwart mentors and sponsors and […]

SHOWCASE: Precision Medicine: Patient-Centric Healthcare Puts the Focus on Precision Medicine

April 1, 2020

Precision medicine is changing the way that healthcare is delivered, moving treatments away from a one-size-fits-all approach and toward tailored treatments. The Precision Medicine Initiative, announced by President Barack Obama during his 2015 State of the Union address, describes precision medicine as “an emerging approach for disease treatment and prevention that takes into account individual […]

Leveraging Real-World Testing Data to Unlock the Promise of Precision Medicine

April 1, 2020

Many patients are alive today who would not be if they had to rely on the one-size-fits-all treatment options that were not significantly increasing survival before the advent of precision medicine (PM). The power of PM derives from the data that characterize each individual patient. Having these specific datasets makes it possible to deliver precision […]

Improving Patient Adherence With Behavioral Health Technology

April 1, 2020

The industry’s shift to outcomes-based, patient-centered care requires new approaches to patient support to achieve adherence and therapeutic success. Today’s patients are also highly motivated information seekers and are taking control of their day-to-day therapy. And, like all modern consumers, they expect outcomes to be personalized, delivered on their terms, powered by technology, and of […]

HBA’s Rising Stars and Luminaries

April 1, 2020

The HBA’s 2020 Rising Stars and Luminaries provide their insights on the trends they are tracking that they believe will impact the industry in the future. In 2020, the Healthcare Businesswomen’s Association is honoring more than 140 extraordinary women representing all facets of the life-sciences industry. These Rising Stars and Luminaries were selected by their […]

Brand Bonds: Agency-Client Relationships

April 1, 2020

Three successful agency and client teams discuss the importance of a positive working relationship. The Chemistry Click Brian Peters Medexus Pharma Having chemistry with people during the agency selection process is most important. If you don’t have that personal connection, it just becomes work, and that is never truly successful. Frank X. Powers Elevate Healthcare […]

Gene Editing: The Future Is Now

April 1, 2020

Genomic editing has truly come of age. In the past few years, the technology has moved from the laboratory to the clinic, with companies beginning to conduct in vivo studies of the technology in various disease states. The gene editing field reached a milestone in March 2020 when for the first time a medicine derived […]

Commanders & Chiefs: Chief Digital Officers

April 1, 2020

More and more companies are elevating the role of chief digital officer to oversee a range of strategies and the integration of technology solutions. Nagaraja Srivatsan Data in Use The biggest trend I am tracking is determining how data can be used effectively to make critical and impactful decisions. In order for digital transformation to […]

Executive Perspective: Bioinformatics Is Changing the Face of Discovery and Development: A Conversation with Bill Moss, CEO, Seven Bridges

April 1, 2020

While the rate of approval of novel life-changing precision medicines is on the rise, the economics facing those who discover, commercialize, and are in need of such medications are untenable. The combination of the increased development costs and more narrowly targeted patient populations of precision medicine have driven down biopharma internal rates of return and […]

FEEDBACK